Sun Pharmaceutical has received a warning letter from the US Food and Drug Administration for violating manufacturing standards at its Halol plant in Gujarat.
What the actual story is?
This plant was being leveraged for many of its new and high margin products. The warning indicates the agency is not satisfied with remedial steps taken by Sun Pharma despite the company claiming the remediation process was on track. Analysts feel it is certainly a very major area of worry for the company.
Actual contents of the warning letter are yet to be disclosed.